Medavita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 218,576 | 253,971 | 246,886 | 290,899 | 285,745 | 273,364 | 261,139 | 342,639 |
| Profit before tax | 11,924 | 4,170 | 21,566 | 22,432 | 27,369 | 17,226 | 15,999 | 34,154 |
| Net profit | 11,328 | 3,961 | 20,512 | 21,313 | 26,006 | 16,370 | 15,204 | 28,422 |
| Equity | 135,756 | 139,717 | 160,229 | 181,542 | 207,548 | 223,918 | 239,122 | 311,628 |
| Liabilities | 77,367 | 79,798 | 70,488 | 68,778 | 75,450 | 63,367 | 60,938 | 77,834 |
| Non-current assets | 14,326 | 21,075 | 16,501 | 14,349 | 9,730 | 6,050 | 3,828 | 20,363 |
| Current assets | 198,797 | 198,440 | 214,216 | 235,971 | 273,268 | 281,235 | 296,232 | 369,732 |
| Total assets | 213,123 | 219,515 | 230,717 | 250,320 | 282,998 | 287,285 | 300,060 | 390,095 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 45,938 | 43,678 | 47,610 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.8% | +16.2% | -2.8% | +17.8% | -1.8% | -4.3% | -4.5% | +31.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.3% | 1.8% | 8.9% | 8.5% | 9.2% | 5.7% | 5.1% | 7.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 8.3% | 2.8% | 12.8% | 11.7% | 12.5% | 7.3% | 6.4% | 9.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.2% | 1.6% | 8.3% | 7.3% | 9.1% | 6.0% | 5.8% | 8.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.5% | 1.6% | 8.7% | 7.7% | 9.6% | 6.3% | 6.1% | 10.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 109,288 | 126,986 | 123,443 | 145,450 | 142,873 | 136,682 | 130,570 | 195,794 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medavita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-05-17 | 2022-06-08 | 0.35 |
| 2022-04-25 | 2022-05-12 | 0.35 |
| 2022-03-16 | 2022-03-17 | 388.73 |
Medavita - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-05 | 2026-06-05 | 1.62 |
| 2026-01-29 | 2026-02-03 | 0.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medavita, UAB (code 144995299) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 342.6K in revenue, up 31.2% year on year and 25.3% over two years from 2023. Net profit increased to EUR 28.4K in 2025 from EUR 15.2K in 2024 and EUR 16.4K in 2023, while the profit margin improved to 8.3% from 5.8% and 6.0% in the previous two years. The business showed a steady strengthening of profitability alongside faster sales growth in the latest year. Total assets reached EUR 390.1K at the end of 2025, compared with EUR 300.1K in 2024 and EUR 287.3K in 2023. Equity stood at EUR 311.6K and liabilities at EUR 77.8K, indicating a solid capital structure and a debt-to-equity ratio of 0.25. The equity ratio was 79.9%. Return on equity was 9.1% and return on assets 7.3%. Revenue per employee was EUR 342.6K, matching the latest revenue figure.